221 related articles for article (PubMed ID: 19785557)
21. Hemostatic plug: novel technique for closure of percutaneous nephrostomy tract.
Abbott JE; Cicic A; Jump RW; Davalos JG
J Endourol; 2015 Mar; 29(3):263-9. PubMed ID: 25157538
[TBL] [Abstract][Full Text] [Related]
22. Questioning the wisdom of tubeless percutaneous nephrolithotomy (PCNL): a prospective randomized controlled study of early tube removal vs tubeless PCNL.
Mishra S; Sabnis RB; Kurien A; Ganpule A; Muthu V; Desai M
BJU Int; 2010 Oct; 106(7):1045-8; discussion 1048-9. PubMed ID: 20151965
[TBL] [Abstract][Full Text] [Related]
23. Using and choosing a nephrostomy tube after percutaneous nephrolithotomy for large or complex stone disease: a treatment strategy.
Kim SC; Tinmouth WW; Kuo RL; Paterson RF; Lingeman JE
J Endourol; 2005 Apr; 19(3):348-52. PubMed ID: 15865526
[TBL] [Abstract][Full Text] [Related]
24. Pathologic evaluation of hemostatic agents in percutaneous nephrolithotomy tracts in a porcine model.
Lipkin ME; Mancini JG; Simmons WN; Raymundo ME; Yong DZ; Wang AJ; Ferrandino MN; Albala DM; Preminger GM
J Endourol; 2011 Aug; 25(8):1353-7. PubMed ID: 21740197
[TBL] [Abstract][Full Text] [Related]
25. [Use of a gelatine-thrombin matrix for closure of the access tract without a nephrostomy tube in minimally invasive percutaneous nephrolitholapaxy].
Schilling D; Winter B; Merseburger AS; Anastasiadis AG; Walcher U; Stenzl A; Nagele U
Urologe A; 2008 May; 47(5):601-7. PubMed ID: 18311555
[TBL] [Abstract][Full Text] [Related]
26. Effects of commonly used hemostatic agents on the porcine collecting system.
Kim IY; Eichel L; Edwards R; Uribe C; Chou DS; Abdelshehid C; Ahlering M; White S; Woo E; McDougall E; Clayman RV
J Endourol; 2007 Jun; 21(6):652-4. PubMed ID: 17638564
[TBL] [Abstract][Full Text] [Related]
27. Comparison of outcomes in totally tubeless percutaneous nephrolithotomy according to nephrostomy tract sealing with fibrin versus gelatin matrix: a propensity score matching study.
Kim JJ; Suh YS; Han DH
Urolithiasis; 2020 Apr; 48(2):151-158. PubMed ID: 30868183
[TBL] [Abstract][Full Text] [Related]
28. Tubeless percutaneous nephrolithotomy: call of the day.
Rana AM; Mithani S
J Endourol; 2007 Feb; 21(2):169-72. PubMed ID: 17338615
[TBL] [Abstract][Full Text] [Related]
29. Use of absorbable gelatin sponge as an adjunct to "totally tubeless percutaneous nephrolithotomy".
Singh P; Mandhani A
Arch Esp Urol; 2009 Jul; 62(6):423-9. PubMed ID: 19736373
[TBL] [Abstract][Full Text] [Related]
30. Tubeless percutaneous nephrolithotomy: is it really less morbid?
Singh I; Singh A; Mittal G
J Endourol; 2008 Mar; 22(3):427-34. PubMed ID: 18355137
[TBL] [Abstract][Full Text] [Related]
31. Modified-PCNL without modified instruments: a description of technique.
Lipsky MJ; Shapiro EY; Cha DY; Gupta M
J Endourol; 2013 Jun; 27(6):684-7. PubMed ID: 23268559
[TBL] [Abstract][Full Text] [Related]
32. Tubeless percutaneous nephrolithotomy in selected patients.
Lojanapiwat B; Soonthornphan S; Wudhikarn S
J Endourol; 2001 Sep; 15(7):711-3. PubMed ID: 11697402
[TBL] [Abstract][Full Text] [Related]
33. Are we fearful of tubeless percutaneous nephrolithotomy? Assessing the need for tube drainage following percutaneous nephrolithotomy.
Abbott JE; Deem SG; Mosley N; Tan G; Kumar N; Davalos JG
Urol Ann; 2016; 8(1):70-5. PubMed ID: 26834406
[TBL] [Abstract][Full Text] [Related]
34. Tubeless percutaneous nephrolithotomy (PCNL) with reversed Polaris Loop stent: reduced postoperative pain and narcotic use.
Berkman DS; Lee MW; Landman J; Gupta M
J Endourol; 2008 Oct; 22(10):2245-9. PubMed ID: 18937589
[TBL] [Abstract][Full Text] [Related]
35. [Prevention of bleeding during tubeless percutaneous nephrolithotomy].
S Merinov D; Gurbanov SS; Artemov AV; Arustamov LD; Epishov VA
Urologiia; 2019 Sep; (4):38-43. PubMed ID: 31535803
[TBL] [Abstract][Full Text] [Related]
36. Randomized trial comparing modified tubeless percutaneous nephrolithotomy with tailed stent with percutaneous nephrostomy with small-bore tube.
Choi M; Brusky J; Weaver J; Amantia M; Bellman GC
J Endourol; 2006 Oct; 20(10):766-70. PubMed ID: 17094752
[TBL] [Abstract][Full Text] [Related]
37. Tubeless percutaneous nephrolithotomy with non-absorbable hemostatic sealant (Quikclot®) versus nephrostomy tube placement: a propensity score-matched analysis.
Koo KC; Park SU; Jang HS; Hong CH
Urolithiasis; 2015 Nov; 43(6):527-33. PubMed ID: 26123752
[TBL] [Abstract][Full Text] [Related]
38. The management of the access tract after percutaneous nephrolithotomy.
Hüsch T; Reiter M; Mager R; Steiner E; Herrmann TR; Haferkamp A; Schilling D
World J Urol; 2015 Dec; 33(12):1921-8. PubMed ID: 25903804
[TBL] [Abstract][Full Text] [Related]
39. Does sealing of the tract with absorbable gelatin (Spongostan) facilitate tubeless PCNL? A prospective study.
Singh I; Saran RN; Jain M
J Endourol; 2008 Nov; 22(11):2485-93. PubMed ID: 18928387
[TBL] [Abstract][Full Text] [Related]
40. The use of adjunctive hemostatic agents for tubeless percutaneous nephrolithotomy.
Choe CH; L'Esperance JO; Auge BK
J Endourol; 2009 Oct; 23(10):1733-8. PubMed ID: 19785556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
